Arbutus Biopharma (ABUS) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/18/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
| (NASDAQ: ABUS) | Delayed: 4.22 -0.07 (1.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.29 | 52 Week High | $5.88 | |||
| Open | $4.29 | 52 Week Low | $2.65 | |||
| Day High | $4.29 | P/E | N/A | |||
| Day Low | $4.18 | EPS | $0.00 | |||
| Volume | 4,541,669 | |||||
